BR9712100A - Intermediários e processo para preparar olanzapina. - Google Patents

Intermediários e processo para preparar olanzapina.

Info

Publication number
BR9712100A
BR9712100A BR9712100-2A BR9712100A BR9712100A BR 9712100 A BR9712100 A BR 9712100A BR 9712100 A BR9712100 A BR 9712100A BR 9712100 A BR9712100 A BR 9712100A
Authority
BR
Brazil
Prior art keywords
intermediates
preparing
preparing olanzapine
olanzapine
olazapine
Prior art date
Application number
BR9712100-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Charles A Bunnell
Samuel D Larsen
John R Nichols
Susan M Reutzel
Gregory A Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9712100(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9712100A publication Critical patent/BR9712100A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9712100-2A 1996-09-23 1997-09-18 Intermediários e processo para preparar olanzapina. BR9712100A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23
PCT/US1997/016499 WO1998012199A1 (en) 1996-09-23 1997-09-18 Intermediates and process for preparing olanzapine

Publications (1)

Publication Number Publication Date
BR9712100A true BR9712100A (pt) 1999-08-31

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712100-2A BR9712100A (pt) 1996-09-23 1997-09-18 Intermediários e processo para preparar olanzapina.

Country Status (36)

Country Link
US (1) US6020487A (US06373033-20020416-M00018.png)
EP (1) EP0831098B1 (US06373033-20020416-M00018.png)
JP (2) JP2001500877A (US06373033-20020416-M00018.png)
KR (1) KR100560015B1 (US06373033-20020416-M00018.png)
CN (1) CN1122036C (US06373033-20020416-M00018.png)
AR (1) AR013838A1 (US06373033-20020416-M00018.png)
AT (1) ATE209208T1 (US06373033-20020416-M00018.png)
AU (1) AU719441B2 (US06373033-20020416-M00018.png)
BR (1) BR9712100A (US06373033-20020416-M00018.png)
CA (1) CA2265712C (US06373033-20020416-M00018.png)
CO (1) CO4910140A1 (US06373033-20020416-M00018.png)
CZ (1) CZ299248B6 (US06373033-20020416-M00018.png)
DE (1) DE69708428T2 (US06373033-20020416-M00018.png)
DK (1) DK0831098T3 (US06373033-20020416-M00018.png)
EA (1) EA001642B1 (US06373033-20020416-M00018.png)
EG (1) EG23861A (US06373033-20020416-M00018.png)
ES (1) ES2166051T3 (US06373033-20020416-M00018.png)
HK (1) HK1009807A1 (US06373033-20020416-M00018.png)
HU (1) HU226484B1 (US06373033-20020416-M00018.png)
ID (1) ID27275A (US06373033-20020416-M00018.png)
IL (1) IL128962A (US06373033-20020416-M00018.png)
IN (1) IN187156B (US06373033-20020416-M00018.png)
MY (1) MY125565A (US06373033-20020416-M00018.png)
NO (1) NO323980B1 (US06373033-20020416-M00018.png)
NZ (1) NZ334448A (US06373033-20020416-M00018.png)
PE (1) PE110398A1 (US06373033-20020416-M00018.png)
PL (3) PL196069B1 (US06373033-20020416-M00018.png)
PT (1) PT831098E (US06373033-20020416-M00018.png)
RS (1) RS49598B (US06373033-20020416-M00018.png)
SI (1) SI0831098T1 (US06373033-20020416-M00018.png)
SV (1) SV1997000081A (US06373033-20020416-M00018.png)
TR (1) TR199900640T2 (US06373033-20020416-M00018.png)
TW (1) TW470746B (US06373033-20020416-M00018.png)
UA (1) UA59371C2 (US06373033-20020416-M00018.png)
WO (1) WO1998012199A1 (US06373033-20020416-M00018.png)
ZA (1) ZA978515B (US06373033-20020416-M00018.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0114031A (pt) * 2000-08-31 2003-09-09 Reddy S Lab Ltd Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2471341C (en) 2001-12-24 2012-01-24 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
WO2003101997A1 (en) * 2002-05-31 2003-12-11 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
DE602004014264D1 (de) * 2003-12-22 2008-07-17 Teva Pharma Verfahren zur herstellung von olanzapin
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
US7910577B2 (en) * 2004-11-16 2011-03-22 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンii型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
AU720366B2 (en) * 1996-09-23 2000-06-01 Eli Lilly And Company Olanzapine dihydrate D

Also Published As

Publication number Publication date
NO991382D0 (no) 1999-03-22
EA199900326A1 (ru) 1999-08-26
DE69708428T2 (de) 2002-07-04
PE110398A1 (es) 1999-01-14
EP0831098A2 (en) 1998-03-25
EG23861A (en) 2007-11-18
NO323980B1 (no) 2007-07-30
NO991382L (no) 1999-03-22
AU4484197A (en) 1998-04-14
PT831098E (pt) 2002-04-29
AU719441B2 (en) 2000-05-11
SI0831098T1 (en) 2002-04-30
ID27275A (id) 2001-03-22
DK0831098T3 (da) 2002-05-21
YU15599A (sh) 2001-12-26
TR199900640T2 (xx) 1999-06-21
IL128962A (en) 2003-01-12
PL332482A1 (en) 1999-09-13
PL196069B1 (pl) 2007-12-31
DE69708428D1 (de) 2002-01-03
CN1122036C (zh) 2003-09-24
EP0831098A3 (en) 1998-04-29
JP2009242407A (ja) 2009-10-22
PL196068B1 (pl) 2007-12-31
EP0831098B1 (en) 2001-11-21
MY125565A (en) 2006-08-30
PL194565B1 (pl) 2007-06-29
TW470746B (en) 2002-01-01
IL128962A0 (en) 2000-02-17
SV1997000081A (es) 1999-01-14
RS49598B (sr) 2007-06-04
IN187156B (US06373033-20020416-M00018.png) 2002-02-16
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
HK1009807A1 (en) 1999-06-11
ATE209208T1 (de) 2001-12-15
CA2265712A1 (en) 1998-03-26
JP2001500877A (ja) 2001-01-23
ZA978515B (en) 1999-03-23
HUP0000066A2 (hu) 2000-06-28
KR20000048520A (ko) 2000-07-25
CA2265712C (en) 2006-10-31
UA59371C2 (uk) 2003-09-15
HUP0000066A3 (en) 2000-11-28
AR013838A1 (es) 2001-01-31
CZ99099A3 (cs) 1999-11-17
HU226484B1 (en) 2009-03-02
EA001642B1 (ru) 2001-06-25
CO4910140A1 (es) 2000-04-24
ES2166051T3 (es) 2002-04-01
KR100560015B1 (ko) 2006-03-15
US6020487A (en) 2000-02-01
CN1234802A (zh) 1999-11-10
CZ299248B6 (cs) 2008-05-28

Similar Documents

Publication Publication Date Title
BR9712100A (pt) Intermediários e processo para preparar olanzapina.
PT916675E (pt) Processo para preparacao de sildenafil
BR9706447A (pt) Processo para a preparação de oxo-álcoois superiores
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
BR9502748A (pt) Terminal receptor e processo para a fabricação de um terminal receptor.
BR9907230B1 (pt) processo para a preparaÇço de um macrâmero.
ITMI931295A0 (it) Processo per la preparazione di cumene
BR9706465A (pt) Processo para a preparação contínua de metilmercaptano
BR9508320A (pt) Processo para a preparação de um composto e cultura biologicamente
BR9400604A (pt) Processo para a preparação de 1,1,1,3,3-pentafluorpropano
BR9800557A (pt) Processo contínuo para preparação de 4-aminopiperidinas
BR9605759A (pt) Processo contínuo para preparação de 4-mino-2,2,6,6-tetrametilpiperidina
BR9905342A (pt) Caixa de câmbio
BR9400338A (pt) Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano
BR9807988B1 (pt) processo para a preparaÇço de um composto, e, composto.
BR9707173A (pt) Processo para a preparação de um composto e composto
BR9506646A (pt) Procedimento de alinhamento de grupos
PT915874E (pt) Processo de preparacao de valaciclovir e intermediarios relevantes
BR9403539A (pt) Um processo para a preparação de 5 (4H)-tetrazolinonas 1-tetrazolinonas 1-substituídas
BR9712773A (pt) Processo para a sìntese de benzotiofenos
BR9706239A (pt) Processo para preparação de 3-(1-hidroxifenil-1-alcoxiimino-metil)dioxazinas
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
BR9509424A (pt) Processo e disposição para separar sinais que operam no mesmo canal
BR9407024A (pt) Processo para a preparação de 4,6-diamino-5-cianopirimidinas substituídas

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL.7: C07D 415/04, C07D 243/10, A61K 31/55

Ipc: C07D 495/04 (2007.01), C07D 243/10 (2007.01), A61K

B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: COM A PETICAO NO020070092567, DE 09/07/2007, A REQUERENTE APRESENTOU MANIFESTACAO SOBRE O PARECER PUBLICADO NA RPI 1892, DE 10/04/2007, COM NOVAS VIAS DO QUADRO REIVINDICATORIO (TOTAL DE 15 REIVINDICACOES). NO ENTANTO, NA PETICAO NO 035063, DE 14/09/2000, ONDE A REQUERENTE SOLICITOU O EXAME DO PRESENTE PEDIDO, E INDICADO O PAGAMENTO RELATIVO A 13 REIVINDICACOES. DESSE MODO, A FIM DE DAR CONTINUIDADE AO EXAME DO PEDIDO, A REQUERENTE DEVERA COMPLEMENTAR A RETRIBUICAO EQUIVALENTE A 02 (DUAS) REIVINDICACOES EXCEDENTES

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO UMA VEZ QUE ESTE NAO ATENDE AOS ARTIGOS 8O E 13 DA LEI 9279/96 (LPI).

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.